Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis
- 1 March 2004
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 363 (9414) , 1031-1037
- https://doi.org/10.1016/s0140-6736(04)15838-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitisArchives of Disease in Childhood, 2003
- Respiratory syncytial virus bronchiolitis: Disease severity, interleukin‐8, and virus genotype*Pediatric Pulmonology, 2002
- The pathogenesis of respiratory syncytial virus disease in childhoodBritish Medical Bulletin, 2002
- Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathologyEuropean Journal of Immunology, 2001
- Macrophage Inflammatory Protein–1α (Not T Helper Type 2 Cytokines) Is Associated with Severe Forms of Respiratory Syncytial Virus BronchiolitisThe Journal of Infectious Diseases, 2001
- Immune-mediated disease pathogenesis in respiratory syncytial virus infectionImmunopharmacology, 2000
- IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthmaJournal of Allergy and Clinical Immunology, 2000
- Respiratory Syncytical Virus–induced Chemokine Expression in the Lower AirwaysAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Interleukin 9: A candidate gene for asthmaProceedings of the National Academy of Sciences, 1997
- Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian childrenThe Journal of Pediatrics, 1992